Zaragoza-Saavedra JJM

Language: Spanish
References: 9
Page: 20-21
PDF size: 131.00 Kb.

Text Extraction

No abstract.

REFERENCES

1. World Health Organization. Maternal mortality: Fact Sheet 348. 2012. Available in: http://www.who.int/mediacentre/factsheets/

2. Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. RCOG Green-top Guideline No. 52. London: Royal College of O, Gynaecologists; 2009.

3. RCOG. Antepartum Haemorrhage, Green‐top Guideline No. 63. Royal College of Obstetrics & Gynaecology, London; 2011. Available in: http://www.rcog.org.uk/files/rcog-corp/GTG63_05122011APH.pdf.

4. Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003-05. BJOG. 2007;114:1388-1396.

5. O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best practice and research. Clinical Obstetrics and Gynaecology. 2003;17:385-396.

6. de Lloyd L, Bovington R, Kaye A, Collis RE, Rayment R, Sanders J, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20:135-141.

7. Collins PW, Lilley G, Bruynseels D, Laurent DB, Cannings-John R, Precious E, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood. 2014;124:1727-1736.

8. Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 2009;23:167-176.

9. Larsson C, Saltvedt S, Wiklund I, Pahlen S, Andolf E. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand. 2006;85:1448-1452.